S99.239
Salter-Harris Type III physeal fracture of phalanx of unspecified toe
Clinical Classification Guidelines
Medical Intelligence & Overview
A Salter-Harris Type III physeal fracture involves a break through the growth plate and the adjacent bone, affecting the growth of the affected toe. This type of fracture specifically impacts the phalanx, which is one of the bones in the toe. Recognized under ICD-10 code S99.239, this injury often results from trauma or force applied to the toe, such as stubbing or dropping something heavy on it. Proper diagnosis and management are essential to ensure healing and prevent long-term deformity or growth issues.
Causes & Symptoms
Clinical Causes: Trauma from stubbing the toe forcefully Dropping heavy objects on the toe Sports injuries involving the toes Sudden twisting or bending of the toe Accidental impact during falls or collisions
Key Symptoms: Pain and tenderness at the base of the toe Swelling around the toe joint Bruising or discoloration of the toe Difficulty moving or bending the toe Visible deformity or misalignment (in some cases)
Diagnostic & Treatment
Diagnosis Path: To confirm the diagnosis, healthcare providers typically perform a physical examination followed by imaging studies. X-rays are the primary diagnostic tool used to identify the type and extent of the fracture. It is important for these images to clearly show the growth plate and surrounding bone to determine the specific type of fracture. In some cases, additional imaging such as MRI or CT scans may be necessary if the fracture is complex or not clearly visible on X-ray.
Treatment Protocols: Treatment strategies depend on the severity and location of the fracture and may include:
Clinical Advice & FAQs
Billing Guidance
Is S99.239 a billable ICD-10 code?
Yes, S99.239 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report S99.239?
Clinical documentation must specify the nature of Salter-Harris Type III physeal fracture of phalanx of unspecified toe and any associated comorbidities for accurate reporting.
Cite this Clinical Reference